Basic information
Biomarker: CTNNB1
Biomarker subtype: gene
Clinical application: prognosis(unfavorable)
Histology type: endometrioid endometrial carcinoma
Stage: early stage
Cohort characteristics
Country: Spain
Region: Madrid
Study type: single-centre retrospective cohort study
Followed up time : 80.5 months
Cohort age: 64.04±10.38
Protocol age: 64.19±10.06
Control age: 62.47±13.54
Total number | Group I | Group I number | Group II | Group II number | Group III | Group III number | Group IV | Group IV number |
---|---|---|---|---|---|---|---|---|
218 | CTNNB1 exon 3 mutated | 19 | CTNNB1 exon 3 wild-type | 199 |
Sample information
Sample type : tissue
Clinical method: Immunohistochemical staining/Sanger sequencing/ PCR
Expression pattern : CTNNB1 exon 3 mutation
Disease information
Statictics: Mean (SD)
Cohort age: 64.04±10.38
Protocol age: 64.19±10.06
Control age: 62.47±13.54
Related information
Description: CTNNB1 exon 3 mutation has a negative impact on disease-free survival in low-grade, early-stage EECs.
Survival figure legend: Kaplan–Meier curves for disease-free survival (DFS) and overall survival (OS) in low-grade, early-stage EECs. DFS (A) and OS (B) according to the presence of CTNNB1 exon 3 mutation
Survival curve link: https://pubmed.ncbi.nlm.nih.gov/34420090/#&gid=article-figures&pid=fig-1-uid-0
Expression figure legend: Immunohistochemical expression of LEF1 and beta-catenin.
Expression figure link: https://pubmed.ncbi.nlm.nih.gov/34420090/#&gid=article-figures&pid=fig-2-uid-1
Approved symbol: CTNNB1
Approved name: catenin beta 1
Locus type: gene with protein product
HGNC ID: HGNC:2514
HGNC link: https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:2514
Symbol status: Approved
Previous symbols: CTNNB1
Alias symbols: beta-catenin armadillo
Alternative gene group name: ARM repeat containing
Subgroup: Armadillo like helical domain containing (ARMH)$ Catenins
OMIM: 116806
Omim link: https://www.omim.org/entry/116806
NCBI name: 1499
NCBI link: https://www.ncbi.nlm.nih.gov/gene/1499
Summary: The protein encoded by this gene is part of a complex of proteins that constitute adherens junctions (AJs). AJs are necessary for the creation and maintenance of epithelial cell layers by regulating cell growth and adhesion between cells. The encoded protein also anchors the actin cytoskeleton and may be responsible for transmitting the contact inhibition signal that causes cells to stop dividing once the epithelial sheet is complete. Finally, this protein binds to the product of the APC gene, which is mutated in adenomatous polyposis of the colon. Mutations in this gene are a cause of colorectal cancer (CRC), pilomatrixoma (PTR), medulloblastoma (MDB), and ovarian cancer. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2016]
Expression: Ubiquitous expression in placenta (RPKM 94.7), thyroid (RPKM 78.7) and 25 other tissues
NCBI gene expression https://www.ncbi.nlm.nih.gov/gene/1499#gene-expression
BP term ID: GO:0007403 | GO:0061324
BP term name: glial cell fate determination | canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation
CC term ID: GO:0034750 |GO:1990711 |GO:0070369 | GO:0071664
CC term name: Scrib-APC-beta-catenin complex | beta-catenin-ICAT complex | beta-catenin-ICAT complex |catenin-TCF7L2 complex